MedAssets MHIS Company Profile
MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve financial strength by implementing spend management and revenue cycle management solutions that help control cost, improve margins and cash flow, increase regulatory compliance and optimize operational efficiency. MedAssets serves more than 180 health systems, 4,000 hospitals and 75,000 non-acute healthcare providers. For more information, visit www.medassets.com.
News Articles
MedAssets to Present at the J.P. Morgan Healthcare Conference on January 9, 2013
MedAssets, Inc. (NASDAQ: MDAS) announced that its management team will present at the 31st Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013 at 10:00 am PT (1...
MedAssets to Present at the Baird Health Care Conference on September 5th
MedAssets, Inc. (NASDAQ: MDAS) announced that its management team will present at the Baird 2012 Health Care Conference on Wednesday, September 5th at 10:10 am ET in New York City...
MedAssets to Present at the Piper Jaffray Healthcare Conference on November 28th
MedAssets, Inc. (NASDAQ: MDAS) announced that its management team will present at the 24th annual Piper Jaffray Healthcare Conference on Wednesday, November 28th at 9:30 am ET in...
MedAssets to Present at Two Investment Conferences on May 14 and 21, 2013
MedAssets, Inc. (NASDAQ: MDAS) today announced that its management team will participate in two investment conferences during the month of May. The company will pr...
MedAssets, Inc. (NASDAQ: MDAS) announced that its management team will present at the Raymond James 34th Annual Institutional Investors Conference on Monday, March 4, 2013 at 2:50...
MedAssets to Webcast its 2013 Investor Day on February 28th
MedAssets, Inc. (NASDAQ: MDAS) today announced that it will webcast its 2013 Investor Day meeting on Thursday, February 28, 2013. The event is being held in New York City, and is...
MedAssets 2nd-qtr results beat; sees FY above estimates
Aug 1 (Reuters) - Healthcare IT company MedAssets Inc posted quarterly results that comfortably beat analysts' estimates and forecast a strong full year, buoyed by continued growth across all its seg...
MedAssets to Report First Quarter 2013 Financial Results on Wednesday, May 1st after 4:00 p.m. ET
MedAssets, Inc. (NASDAQ: MDAS) today announced that it plans to release its financial results for the first quarter ended March 31, 2013 after 4:00 p.m. ET on Wednesday, May 1, 20...
Drugs and Medications
None
PubMed Articles
Effects of "Diagnosis Threat" on Cognitive and Affective Functioning Long After Mild Head Injury.
Persistent cognitive complaints are common following a mild head injury (MHI), but deficits are rarely detected on neuropsychological tests. Our objective was to examine the effect of symptom expectat...
Clinical Trials
None
Companies
MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve financial strength by implementing spend management and revenue cycle management solutions that help control...
MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their financial strength by implementing spend management and revenue cycle solutions that help control cost...
MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their financial strength by implementing spend and clinical resource management and revenue cycle management...
Our mission is to be the recognized market share leader in the healthcare business chain services segment in which we compete, as measured by the satisfaction and loyalty of our employees, customers,...
MedAssets and Prodigo Solutions
Prodigo Solutions was launched by healthcare supply chain executives to accelerate savings and automation in the healthcare supply chain. Based on its expertise in healthcare supp...
More Information about "MedAssets MHIS" on BioPortfolio
We have published hundreds of MedAssets MHIS news stories on BioPortfolio along with dozens of MedAssets MHIS Clinical Trials and PubMed Articles about MedAssets MHIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MedAssets MHIS Companies in our database. You can also find out about relevant MedAssets MHIS Drugs and Medications on this site too.
